Literature DB >> 13616513

[Inhibition of tumor glycolysis by 2-methyl-1, 4-naphthoqulnone].

H TIEDEMANN, H J RISSE, J BORN.   

Abstract

Entities:  

Keywords:  CARBOHYDRATES/metabolism; NAPHTHOQUINONES; NEOPLASMS/experimental

Mesh：

Substances：

Year:  1958        PMID： 13616513

Source DB:  PubMed          Journal:  Z Naturforsch B        ISSN： 0044-3174            Impact factor:   1.047


× No keyword cloud information.
  7 in total

1.  [On the effect of phenanthrenequinone (9,10) and its water-soluble transport form on glycolysis and respiration in the ascites tumor].

Authors:  H TIEDEMANN; H J RISSE
Journal:  Experientia       Date:  1960-07-15

2.  [On the relation between the inhibition of glycolysis and the transplantability of tumor cells].

Authors:  J PUETTER
Journal:  Z Krebsforsch       Date:  1961

3.  [Carcinostasis with heterocyclic derivatives of 2-amino-1,4-naphthoquinone in transplantation-tumors].

Authors:  E Grundmann; L Jühling; J Pütter; H J Seidel
Journal:  Z Krebsforsch       Date:  1969

4.  [The inhibition of nucleic acid synthesis and transplantibility of Ehrlich ascites tumor cells by natulan, trenimon and p-benzoquinone].

Authors:  F Hölzel; E Wulfmeyer; I Schwencke; H Maass
Journal:  Z Krebsforsch       Date:  1967

5.  [Studies on the thymidine-triphosphate synthesis in malignant tumors. II. Effect of hyperthermia, Vitamin K and Cytotoxic agents (author's transl)].

Authors:  D Kummer
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1977-01-21

6.  Studies of potential radiosensitizing agents. The effect of 2-methyl-1:4-naphthohydroquinone diphosphate (synkavit) on the level of adenosine triphosphate in mouse ascites tumour.

Authors:  B CHIPPERFIELD; D H MARRIAN
Journal:  Br J Cancer       Date:  1962-09       Impact factor: 7.640

7.  Studies of potential radiosensitizing agents. Inhibition of nucleic acid synthesis by Synkavit (2-methyl-1,4-naphthaquinol bis disodium phosphate) in Ehrlich mouse ascites tumour cells.

Authors:  P R Harrison
Journal:  Br J Cancer       Date:  1968-06       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.